Allurion Technologies (Allurion Technologies) Days Sales Outstanding : 253.96 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Allurion Technologies Days Sales Outstanding?

Allurion Technologies's average Accounts Receivable for the three months ended in Dec. 2023 was $22.92 Mil. Allurion Technologies's Revenue for the three months ended in Dec. 2023 was $8.24 Mil. Hence, Allurion Technologies's Days Sales Outstanding for the three months ended in Dec. 2023 was 253.96.

The historical rank and industry rank for Allurion Technologies's Days Sales Outstanding or its related term are showing as below:

ALUR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 65.21 Med: 102.82 Max: 177.13
Current: 177.13

During the past 3 years, Allurion Technologies's highest Days Sales Outstanding was 177.13. The lowest was 65.21. And the median was 102.82.

ALUR's Days Sales Outstanding is ranked worse than
91.7% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.21 vs ALUR: 177.13

Allurion Technologies's Days Sales Outstanding increased from Dec. 2022 (139.59) to Dec. 2023 (253.96).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Allurion Technologies Days Sales Outstanding Historical Data

The historical data trend for Allurion Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allurion Technologies Days Sales Outstanding Chart

Allurion Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Days Sales Outstanding

65.21

102.82

162.27

Allurion Technologies Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial				139.59	189.15	192.04	133.38	253.96

Competitive Comparison of Allurion Technologies's Days Sales Outstanding

For the Medical Devices subindustry, Allurion Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Allurion Technologies's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Allurion Technologies's Days Sales Outstanding falls into.

Allurion Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Allurion Technologies's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (29.346	+	18.194)	/	2 )	/	53.467	*	365
=	23.77					/	53.467	*	365
=	162.27

Allurion Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (27.644	+	18.194)	/	2 )	/	8.235	*	365 / 4
=	22.919					/	8.235	*	365 / 4
=	253.96

Allurion Technologies (NYSE:ALUR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Allurion Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Allurion Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Allurion Technologies (Allurion Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allurion Technologies Inc (NYSE:ALUR) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Huron Drive, Natick, MA, USA, 01760

Website

Allurion Technologies Inc is a leading medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Executives

Omar Ishrak	director	710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432
Nicholas Sheridan Lewin	director	3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Krishna K. Gupta	director, 10 percent owner	307 HARVARD ST, CAMBRIDGE MA 02139
Christopher J Geberth	officer: Chief Financial Officer	11 HURON DRIVE, SUITE 200, NATICK MA 01760
Michael R Davin	director	C/O CYNOSURE, INC., 5 CARLISLE ROAD, WESTFORD MA 01886
Larson Douglas Hudson	director	11 HURON DRIVE, SUITE 200, NATICK MA 01760
Benoit Chardon	officer: Chief Commercial Officer	11 HURON DRIVE, SUITE 200, NATICK MA 01760
Shantanu Gaur	director, officer: Chief Executive Officer	11 HURON DRIVE, SUITE 200, NATICK MA 01760
Ram Chuttani	officer: Chief Medical Officer	11 HURON DRIVE, SUITE 200, NATICK MA 01760